Publications by authors named "P Mohr"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

222,579

Total Likes

11,948

Extended Reach

479,094

Social Features

79
U
Updated European Consensus Statement on diagnosis and treatment of adult ADHD.
J J S Kooij, D Bijlenga, L Salerno, R Jaeschke, I Bitter, J Balázs, J Thome, G Dom, S Kasper, C Nunes Filipe

February 2019

Videos about Article: user user user 1

4 1 4 72 4 64

View All Article and Social Media Activity
D
Dr Florence Sabin (1871-1953): Her work with Friedrich Ziegler (1860-1936) to make a wax model of the brainstem.
Peter Dean Mohr

J Med Biogr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mental health in patients with rheumatoid arthritis and axial spondyloarthritis: a cross-sectional, case-control tertiary centre study from Czechia.
Marketa Husakova, Veronika Balajkova, Karel Pavelka, Ladislav Senolt, Karolina Kuchaříková, Pavel Mohr

BMJ Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg.
Noah Zimmermann, Julian Kött, Tim Zell, Ali Zeinal Abedini, Chiara L Blomen, Peter Mohr

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. 2023, , 3448.
Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, Thomas K Eigentler, Friedegund Meier, Peter Mohr

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy.
S Dugas-Breit, A Forschner, M Erdmann, R Gutzmer, K C Kähler, P Mohr

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis